The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 431-434

  Nagar, Hans ^a   Dobbs, Stephen ^a   McClelland, H Raymond ^a   Price, John ^a   McCluggage, W Glenn ^b   Grey, Arthur ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS   (United Kingdom)

Author keywords

Diagnostic accuracy; Endometrial cancer; Magnetic resonance imaging; Sensitivity; Specificity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER INVASION; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33750160534     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.016     Document Type: Article

References (14)

1. Connelly P.J., Alberhasky R.C., and Christopherson W.M. Carcinoma of the endometrium: III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 59 5 (1982) 569-575
2. Creasman W.T., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Heintz A.P., et al. Carcinoma of the corpus uteri. J Epidemiol Biostat 6 1 (2001) 47-86
3. Cornelison T.L., Trimble E.L., and Kosary C.L. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol 74 3 (1999) 350-355
4. Berman M.L., Afridi M.A., Kanbour A.I., and Ball H.G. Risk factors and prognosis in stage II endometrial cancer. Gynecol Oncol 14 1 (1982) 49-61
5. Wallin T.E., Malkasian Jr. G.D., Gaffey T.A., O'Brien P.C., and Fountain K.S. Stage II cancer of the endometrium: a pathologic and clinical study. Gynecol Oncol 18 1 (1984) 1-17
6. Onsrud M., Aalders J., Abeler V., and Taylor P. Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment. Gynecol Oncol 13 1 (1982) 76-86
7. Kinkel K., Kaji Y., Yu K.K., Segal M.R., Lu Y., Powell C.B., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 3 (1999) 711-718
8. Matsushita H., Kodama S., Kase H., Kurata H., and Tanaka K. Usefulness of magnetic resonance imaging in the determination of cervical involvement in endometrial cancer. Nippon Sanka Fujinka Gakkai Zasshi 48 9 (1996) 821-826
9. Manfredi R., Mirk P., Maresca G., Margariti P.A., Testa A., Zannoni G.F., et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231 2 (2004) 372-378
10. Seki H., Takano T., and Sakai K. Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR Am J Roentgenol 175 1 (2000) 171-176
11. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Clin Biochem 40 Pt. 4 (2003) 357-363
12. Selman T.J., Khan K.S., and Mann C.H. An evidence-based approach to test accuracy studies in gynecologic oncology: the 'STARD' checklist. Gynecol Oncol 96 3 (2005) 575-578
13. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
14. Leminen A., Forss M., and Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 74 1 (1995) 61-66